Aytu BioPharma, Inc. (AYTU)
Market: NASD |
Currency: USD
Address: Denver Corporate Center III
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Show more
📈 Aytu BioPharma, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$9.00
-
Upside/Downside from Analyst Target:
356.85%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2023 |
- |
$0.050000 |
- |
2023-01-06 |
- |
Stock split |
|
Total Amount for 2023: $0.050000 |
| 2020 |
- |
$0.100000 |
- |
2020-12-09 |
- |
Stock split |
|
Total Amount for 2020: $0.100000 |
| 2018 |
- |
$0.050000 |
- |
2018-08-13 |
- |
Stock split |
|
Total Amount for 2018: $0.050000 |
| 2017 |
- |
$0.050000 |
- |
2017-08-29 |
- |
Stock split |
|
Total Amount for 2017: $0.050000 |
| 2016 |
- |
$0.083333 |
- |
2016-07-01 |
- |
Stock split |
|
Total Amount for 2016: $0.083333 |
📅 Earnings & EPS History for Aytu BioPharma, Inc.
| Date | Reported EPS |
|---|
| 2026-02-10 (estimated upcoming) | - |
| 2025-11-11 (estimated upcoming) | - |
| 2025-09-24 (estimated upcoming) | - |
| 2025-05-13 | - |
| 2025-02-12 | -0.26 |
| 2024-11-13 | 0.44 |
| 2024-09-26 | -0.82 |
| 2024-05-15 | -0.52 |
| 2024-02-14 | -0.04 |
| 2023-11-14 | -1.48 |
| 2023-09-27 | -0.59 |
| 2023-05-11 | -1.93 |
| 2023-02-21 | -1.31 |
| 2022-11-14 | -1.2 |
| 2022-09-27 | -9.8 |
| 2022-05-16 | -35.8 |
| 2022-02-14 | -8.8 |
| 2021-11-15 | -21.8 |
| 2021-09-27 | -15 |
| 2021-05-17 | -28.2 |
| 2021-02-11 | -14 |
| 2020-11-12 | -8 |
| 2020-10-06 | -4 |
| 2020-05-14 | -30 |
| 2020-02-13 | -2 |
📰 Related News & Research
No related articles found for "aytu biopharma".
